10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q3 2012

Filing Information

Form Type	10-Q
Accession Number	`0001104659-12-073441`
Period End Date	20120930
Filing Date	20121102
Fiscal Year	2012
Fiscal Period	Q3
XBRL Instance	cldx-20120930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 76 Cash Flow Statement 63

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.90M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.19M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.10M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$41.41M	USD	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$54.43M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$170.00K	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$32.00K	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	60.81M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.20M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	60.81M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.16M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$78.81M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$54.68M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$7.57M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$9.09M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$24.09M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$24.92M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$409.00K	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$329.00K	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Total Assets	`Assets`	$119.84M	USD	Point-in-time
Total Assets	`Assets`	$97.99M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$935.00K	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.28M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$8.16M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$7.01M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$399.00K	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$219.00K	USD	Point-in-time
Current Portion of Term Loan	`SecuredDebtCurrent`	$5.29M	USD	Point-in-time
Current Portion of Term Loan	`SecuredDebtCurrent`	$6.14M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$14.30M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$15.13M	USD	Point-in-time
Term Loan, less Current Portion	`SecuredLongTermDebt`	$9.01M	USD	Point-in-time
Term Loan, less Current Portion	`SecuredLongTermDebt`	$7.33M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$6.37M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$5.97M	USD	Point-in-time
Total Liabilities	`Liabilities`	$29.27M	USD	Point-in-time
Total Liabilities	`Liabilities`	$28.82M	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at September 30, 2012 and December 31, 2011	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at September 30, 2012 and December 31, 2011	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 60,807,350 and 44,210,636 Shares Issued and Outstanding at September 30, 2012 and December 31, 2011, respectively	`CommonStockValue`	$44.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 60,807,350 and 44,210,636 Shares Issued and Outstanding at September 30, 2012 and December 31, 2011, respectively	`CommonStockValue`	$61.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$335.50M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$271.03M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.65M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.77M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-205.01M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-247.32M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$68.72M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$91.02M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$97.99M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$119.84M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$28.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$103.00K	USD	3 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$65.00K	USD	3 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$40.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$228.00K	USD	3 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$5.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$79.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$5.00K	USD	3 Qtrs
Product Royalties	`RoyaltyRevenue`	$7.22M	USD	3 Qtrs
Product Royalties	`RoyaltyRevenue`	$2.32M	USD	1 Quarter
Product Royalties	`RoyaltyRevenue`	$6.76M	USD	3 Qtrs
Product Royalties	`RoyaltyRevenue`	$3.01M	USD	1 Quarter
Total Revenue	`Revenues`	$2.36M	USD	1 Quarter
Total Revenue	`Revenues`	$3.11M	USD	1 Quarter
Total Revenue	`Revenues`	$7.55M	USD	3 Qtrs
Total Revenue	`Revenues`	$6.83M	USD	3 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$33.65M	USD	3 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$8.59M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$11.77M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$22.61M	USD	3 Qtrs
Royalty	`RoyaltyExpense`	$2.32M	USD	1 Quarter
Royalty	`RoyaltyExpense`	$6.76M	USD	3 Qtrs
Royalty	`RoyaltyExpense`	$3.01M	USD	1 Quarter
Royalty	`RoyaltyExpense`	$7.22M	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$7.37M	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$2.27M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$2.83M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$6.85M	USD	3 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$656.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$836.00K	USD	3 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$1.62M	USD	3 Qtrs
Total Operating Expense	`CostsAndExpenses`	$13.84M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$17.86M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$37.85M	USD	3 Qtrs
Total Operating Expense	`CostsAndExpenses`	$49.08M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-11.48M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-41.53M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-14.75M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-31.02M	USD	3 Qtrs
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$307.00K	USD	3 Qtrs
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$436.00K	USD	3 Qtrs
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$105.00K	USD	1 Quarter
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$144.00K	USD	1 Quarter
Interest Expense	`InterestExpense`	$1.36M	USD	3 Qtrs
Interest Expense	`InterestExpense`	$438.00K	USD	1 Quarter
Interest Expense	`InterestExpense`	$1.23M	USD	3 Qtrs
Interest Expense	`InterestExpense`	$381.00K	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-42.32M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-15.03M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.77M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-32.07M	USD	3 Qtrs
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.85	USD	3 Qtrs
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.75	USD	3 Qtrs
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.25	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.27	USD	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	37.93M	shares	3 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	56.09M	shares	3 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	44.14M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	59.47M	shares	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-42.32M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-15.03M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.77M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-32.07M	USD	3 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$2.00K	USD	3 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$1.00K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-3.00K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-8.00K	USD	3 Qtrs
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-117.00K	USD	1 Quarter
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-89.00K	USD	3 Qtrs
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$121.00K	USD	3 Qtrs
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$52.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-11.89M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-42.19M	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-14.97M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-32.16M	USD	3 Qtrs

Cash Flow Statement 63 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-42.32M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-15.03M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.77M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-32.07M	USD	3 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.70M	USD	3 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.58M	USD	3 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$656.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$836.00K	USD	3 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$1.62M	USD	3 Qtrs
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$96.00K	USD	3 Qtrs
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$420.00K	USD	3 Qtrs
Realized (Gain) Loss on Sales and Maturities of Marketable Securities	`MarketableSecuritiesGainLoss`	$6.00K	USD	3 Qtrs
Realized (Gain) Loss on Sales and Maturities of Marketable Securities	`MarketableSecuritiesGainLoss`	$-5.00K	USD	3 Qtrs
Gain on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$74.00K	USD	3 Qtrs
Gain on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$58.00K	USD	3 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$1.70M	USD	3 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$1.61M	USD	3 Qtrs
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$169.00K	USD	3 Qtrs
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$250.00K	USD	3 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-120.00K	USD	3 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-138.00K	USD	3 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-58.00K	USD	3 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.00K	USD	3 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-15.00K	USD	3 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$80.00K	USD	3 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.50M	USD	3 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$556.00K	USD	3 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$620.00K	USD	3 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-92.00K	USD	3 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-26.29M	USD	3 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-36.46M	USD	3 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$45.43M	USD	3 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$38.35M	USD	3 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$48.22M	USD	3 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$57.90M	USD	3 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$403.00K	USD	3 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$193.00K	USD	3 Qtrs
Proceeds from Sale or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$68.00K	USD	3 Qtrs
Proceeds from Sale or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$218.00K	USD	3 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-12.44M	USD	3 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-10.20M	USD	3 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$62.87M	USD	3 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$35.88M	USD	3 Qtrs
(Payments) Issuance of Term Loan	`ProceedsFromIssuanceOfLongTermDebt`	$-2.65M	USD	3 Qtrs
(Payments) Issuance of Term Loan	`ProceedsFromIssuanceOfLongTermDebt`	$5.00M	USD	3 Qtrs
Payment of Convertible Subordinated Debt	`RepaymentsOfConvertibleDebt`	$12.50M	USD	3 Qtrs
Payments of Other Liabilities	`RepaymentsOfOtherLongTermDebt`	$41.00K	USD	3 Qtrs
Payments of Other Liabilities	`RepaymentsOfOtherLongTermDebt`	$72.00K	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$28.30M	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$60.19M	USD	3 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$2.00K	USD	3 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-8.00K	USD	3 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-8.19M	USD	3 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$11.29M	USD	3 Qtrs
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.90M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$23.19M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$13.10M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.90M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$23.19M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$13.10M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.